000 | 01666 a2200505 4500 | ||
---|---|---|---|
005 | 20250517162113.0 | ||
264 | 0 | _c20170728 | |
008 | 201707s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/WNL.0000000000004149 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBurton, Tina M | |
245 | 0 | 0 |
_aEffects of increasing IV tPA-treated stroke mimic rates at CT-based centers on clinical outcomes. _h[electronic resource] |
260 |
_bNeurology _cJul 2017 |
||
300 |
_a343-348 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBrain Ischemia _xdiagnostic imaging |
650 | 0 | 4 |
_aCerebral Hemorrhage _xdiagnostic imaging |
650 | 0 | 4 | _aDiagnostic Errors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aStroke _xdiagnostic imaging |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLuby, Marie | |
700 | 1 | _aNadareishvili, Zurab | |
700 | 1 | _aBenson, Richard T | |
700 | 1 | _aLynch, John K | |
700 | 1 | _aLatour, Lawrence L | |
700 | 1 | _aHsia, Amie W | |
773 | 0 |
_tNeurology _gvol. 89 _gno. 4 _gp. 343-348 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000004149 _zAvailable from publisher's website |
999 |
_c27321023 _d27321023 |